Professional Documents
Culture Documents
Insights Bullish Near Term Outlook
Insights Bullish Near Term Outlook
US$65-70/bbl earlier). The 2018 average will likely be LCY US$m HK$ 3 mth 12 mth Rating
closer to the higher end of our existing US$70-75/bbl CNOOC 13.42 76,485 16.50 (1.8) 42.8 BUY
forecast, as we anticipate oil prices to stay elevated in PetroChina 5.66 15,244 8.20 (13.7) 12.1 BUY
4Q18. Sinopec 7.44 24,231 9.30 (1.5) 23.4 BUY
Medco Energi 760 903 1,530 (32.4) (6.5) BUY
US shale oil growth is a moderating influence, but Bangchak 36.25 1,523 39.00 2.1 (5.2) BUY
inventory drawdowns will continue. US oil production is Hibiscus Petroleum 0.99 377 1.46 6.5 134.5 BUY
up to around 11.0mmbpd currently, and YTD 2018 Sembcorp Marine 1.68 2,550 2.50 (19.2) 6.7 BUY
average of 10.7mmbpd is about 1.2mmbpd higher than Sembcorp Industries 2.75 3,571 3.90 (7.1) (6.1) BUY
the 2017 average. Pipeline bottlenecks in the Permian Keppel Corp 6.44 8,484 9.00 (15.5) 2.7 BUY
region should ease by 2H19, and US production is likely to Source: DBS Bank, DBSVI, AllianceDBS, Bloomberg Finance L.P.
grow by close to 1.0mmbpd again in 2019. This will Closing price as of 5 Sep 2018
hopefully ensure that there will be no supply-side shocks in
the system, but global inventories will continue to be Summary of earnings and TP revisions for upstream picks
drawn down further and support oil price momentum. Company FY19 Net Profit Target Price
% chg Old New % upside
Sector picks. We have raised our earnings forecasts and TP
for E&P companies (refer to table on the right) factoring
CNOOC +19% HKD 16.00 HKD 16.50 +23%
the upwards revisions in oil price assumptions. Upstream
Petrochina +14% HKD 8.00 HKD 8.20 +45%
players with greater sensitivity to oil prices - CNOOC,
Sinopec +1% HKD 9.30 HKD 9.30 +25%
Petrochina and Medco, remain the preferred proxies to
Medco +4% Rp1,500 Rp1,530 +101%
ride on higher oil prices as broad market sentiment
PTTEP +18% Bt132 Bt135 -3%
improves. Meanwhile, Sinopec should continue to
outperform on the back of earnings resiliency, lucrative Source: DBS Bank, DBSVI, DBSV TH
dividend yield (8-9%) and potential IPO of marketing arm.
Bullishness seems to be returning to the oil market. Oil higher than the 1.2mmbbls reduction we saw in the last
markets had cooled down to an extent in the latter part of round of sanctions. China, the largest importer of Iranian oil
July and August, but bullishness seems to be returning to the with around 35% share currently, will likely find ways to skirt
market as fears of demand disruption from trade wars are around the sanctions, but other countries, including India, will
being replaced by fears of supply shortages once the Iran likely have to reduce exposure, though discussions are
sanctions kick in later in November. We believe the market ongoing to secure some waivers from the US. In any case,
may still not be fully factoring in the impact of these volatility will continue in the near term given the uncertainties
sanctions, as it is difficult to ascertain how much of the and oil prices could test levels even above US$80/bbl in the
2.5mmbpd or so of exports from Iran will be affected, come near term, in our view.
end-2018 and 2019. What is becoming more apparent
though is that the rest of the OPEC cartel may not have Thus, we revise up our oil price forecasts. Brent crude oil
enough spare capacity to ramp up sufficiently to fully offset prices have averaged around US$72/bbl YTD in 2018, and as
the losses from Iran, which is compounded by the fact that we move closer to the imposition of renewed US sanctions on
Venezuelan production continues to fall and unplanned Iran from November 2018, we believe that the supply side will
outages could be expected from the likes of Libya, Nigeria and continue to remain fundamentally tight in the coming
Angola. months, and support higher oil prices in the rest of 2018 and
2019. We are revising up our average Brent crude oil forecasts
Demand-side concerns likely to be overshadowed for now. for 2019 to US$75-80/bbl (from US$65-70/bbl earlier) and
Escalating trade tensions between the US and China have led also introduce 2020 average Brent crude oil forecast of
to concerns about slower economic growth globally, and US$70-75/bbl. 2018 average Brent crude oil price will likely be
export growth and manufacturing sentiment in China and the closer to the higher end of our existing US$70-75/bbl forecast,
rest of the region related to the supply chain are showing as we expect oil prices to stay elevated in 4Q18. The key
some signs of softening. However, we do not believe there forces preventing further upside is demand destruction in oil
will be a material demand shock in the offing. Instead, the importing countries if oil prices rally too high, and increasing
focus in the near term would be how much Iranian exports US shale supplies.
would be affected by the sanctions and whether it would be
120
Brent staged a smart recovery
since 2H17 and is hovering above
100 US$75/bbl levels currently
80
60
0
Jan-11
Jan-12
Jan-13
Jan-14
Jan-09
Jan-10
Jan-15
Jan-16
Jan-17
Jan-18
Jul-11
Jul-13
Jul-14
Jul-15
Jul-16
Jul-09
Jul-10
Jul-12
Jul-17
Jul-18
Page 2
Regional Industry Focus
Oil & Gas
OPEC production trends do not seem to be a big game In the two months since the agreement to boost production,
changer, even after relaxation of production quotas. To recap, Saudi Arabia has upped supplies by about 0.7mmbpd, and
OPEC and its key partner nations including Russia had agreed other Gulf countries have also increased production by close
in the last general meeting in Vienna in June 2018 that they to 0.3mmbpd, but overall OPEC increase is lower at less than
would look to boost supplies by close to 1mmbbpd to offset 0.5mmbbls, as Venezuela production is still in decline mode,
the losses from Venezuela and lend stability to the oil market. and disruptions continue in countries like Libya and Angola.
OPEC production levels have started to move up again but may not be enough to offset Iran losses, going forward
mmbpd
34
33
32
31
30
29
28
27
26
25
Apr-14
Apr-16
Apr-17
Apr-18
Apr-15
Jul-15
Jul-16
Jul-17
Jul-18
Jul-14
Jan-14
Jan-16
Jan-17
Jan-18
Jan-15
Oct-15
Oct-16
Oct-17
Oct-14
kbpd
800
680
600
470
400 290
160
200
-
Saudi Iran Libya Angola Nigeria Venezuela Others Total
Arabia (70)
(200) (130) (130)
(400) (330)
Page 3
Regional Industry Focus
Oil & Gas
OPEC spare capacity is tight. OPEC spare capacity is set to and soon, Iran. Spare capacity is only expected to decline
decline to levels below 2.0mmbbls in 2018 and end the year further in 2019. Historically, OPEC spare capacity levels below
at around 1.5mmbbls, according to EIA data and forecasts, 2.0-2.5mmbbls represent very tight market conditions, not
factoring in the expected production ramp-up in Saudi Arabia, desirable in terms of market stability, as any further
UAE, Kuwait and others to offset the declines from Venezuela unplanned outages could cause supply shocks.
0
1Q 2001
3Q 2002
2Q 2003
1Q 2004
4Q 2004
3Q 2005
2Q 2006
4Q 2007
2Q 2009
1Q 2010
4Q 2010
3Q 2011
2Q 2012
1Q 2013
3Q 2014
1Q 2016
3Q 2017
2Q 2018
1Q 2019
4Q 2019
4Q 2001
1Q 2007
3Q 2008
4Q 2013
2Q 2015
4Q 2016
Meanwhile, Iran export shock looms in November. To recap, cargoes and using Iranian tankers to import oil, enjoying
Iran oil production had previously been affected in 2013-2015 almost free shipping and extended credit periods, similar to
owing to the imposition of sanctions related to Iran’s nuclear the Chinese strategy. But it remains to be seen if India can
activities, and had declined to 2.7mmbpd. Since the lifting of continue to withstand US pressure for too long. Taking all
sanctions in January 2016 however, production recovered these factors into account, we believe Iranian exports and
sharply and in 2017, Iran produced close to 4.7mmbpd of production will likely fall by between 1-1.5mmbpd after US
liquids, of which 3.8mmbpd was crude and the remainder sanctions kick in. Even this decline will ensure a very tight
condensate and hydrocarbon gas liquids. Exports increased in market and further drawdown of inventories worldwide.
tandem to reach 2.5mmbpd in 2017, but that again looks to
be under threat with the US administration set to renew Iran crude oil and condensate exports by destination (2017)
sanctions on Iran from November 2018.
Others
18% China
How much of a shock is the question. Chinese and Indian 24%
imports of Iranian oil will hold the key as they accounted for
roughly 43% of Iranian exports in 2017, with South Korea,
France
Japan and Turkey also taking substantial volumes. While other 5%
countries have either started reducing volumes of Iranian
exports already or trying to secure waivers from the US, China Italy
has opposed the unilateral sanctions and increased purchases 7%
of Iranian oil, now accounting for almost 35% of all Iranian oil J apan India
exports in July 2018, according to ship-tracking data compiled 5% 18%
by Bloomberg. Other countries including key US allies like
Turkey South
South Korea and Japan have not been very successful in 9% Korea
securing waivers from the US and imports of Iranian oil look 14%
likely to be halted soon. India, however, is still taking Iranian Source: US Energy Information Administration (EIA)
Page 4
Regional Industry Focus
Oil & Gas
US inventory drawdowns will continue to support oil price globally tight supply conditions, further declines should be
momentum. US crude inventory levels stood at 405mmbbls at expected in coming months. The US is also offering 11mmbbls
the end of August 2018, and inventories continue to show of oil for sale from its Strategic Petroleum Reserve for delivery
better-than-expected seasonal trends in 2018. Stocks are now between 1 October and 30 November 2018, ahead of the
at the lowest level since July 2015 (just a few months after the sanctions on Iran, as it seeks to restrain energy prices before
glut in US shale supply had caused an oil price crisis), and as the crucial midterm elections in the US.
we go into a seasonally high-demand period combined with
US crude oil inventory levels have been declining sharply since 2H17
mmbbls
600
550
500
450
400
350
300
250
200
Jan-2013
Jan-2014
Apr-2014
Jan-2015
Apr-2015
Jan-2016
Jan-2017
Apr-2017
Jan-2018
Apr-2018
Apr-2013
Jul-2014
Jul-2015
Apr-2016
Jul-2017
Jul-2018
Jul-2013
Jul-2016
Oct-2014
Oct-2015
Oct-2017
Oct-2013
Oct-2016
OECD inventory levels show a similar trajectory. According to fall in the last 11 months. OECD stocks were 32mmbbls below
latest estimates by the International Energy Agency (IEA) in its the 5-year average, according to the data. At 59 days’
latest Oil Market Report (OMR), OECD commercial stocks fell forward demand coverage, this does not leave much room for
by 7mmbbls m-o-m in June 2018 to 2,823mmbbls, the eighth comfort, and underpins upside risk to oil prices.
3000
2800
2600
2400
2200
2000
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Sep-14
Sep-15
Sep-16
Sep-17
May-14
May-15
May-16
May-17
May-18
Jul-14
Nov-14
Jul-15
Nov-15
Jul-16
Nov-16
Jul-17
Nov-17
Jan-14
Jan-15
Jan-16
Jan-17
Jan-18
Page 5
Regional Industry Focus
Oil & Gas
US shale oil growth should hopefully safeguard against supply bottlenecks should, however, ease by 2H19 in our view, and
shocks. US oil production is up to around 11.0mmbpd US production is likely to grow by close to 1.0mmbpd again in
currently, and 2018 YTD average of 10.7mmbpd is about 2019. This will hopefully ensure that there will be no supply-
1.2mmbpd higher than the 2017 average. US onshore rig side shocks in the system, as even that would not be good for
count has increased from 911 at the start of the year to the oil market owing to the associated demand destruction
around 1,037 rigs currently, and optimism continues despite that high oil prices would cause in most countries.
the pipeline constraints in the Permian region. Pipeline
mmbpd
11.5
11.0
10.5
10.0
9.5
9.0
8.5
8.0
7.5
7.0
Apr-14
Apr-15
Apr-16
Apr-17
Apr-18
Jul-14
Jul-16
Jul-17
Jul-18
Jan-14
Jan-15
Jul-15
Jan-17
Jan-18
Jan-16
Oct-14
Oct-16
Oct-17
Oct-15
2500 60
40
2000 20
0
1500
-20
-40
1000
-60
500 -80
-100
0 -120
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-15
Jan-16
Jan-17
Jan-18
Jan-13
Jan-14
Page 6
Regional Industry Focus
Oil & Gas
CNOOC • Best proxy to ride oil price as a pure offshore upstream play (80% crude oil; 20% natural gas)
BUY, HK$16.50 (+23%) • Staying ahead of peers with world class cost control; all-in cost further reduced to ~US$32/bbl in
2Q18
• Higher oil price and capex translating into potential reserve and production increase
Petrochina • Undervalued upstream proxy with E&P accounting for c.60% of valuation
BUY; HK$8.20 (+45%) • Prime beneficiary of ongoing natural gas reform towards market-based pricing that should better
reflect cost and reduce imported gas losses
• Clarity on pipeline nationalisation and favourable sector policies to enhance energy security are re-
rating catalysts
Sinopec • Better earnings resiliency having a good mix of upstream and downstream assets
BUY, HK$9.30 (+25%) • Lucrative dividend yield of 8-9%, backed by strong cash flow generation and solid balance sheet
• Potential IPO of marketing arm unlocks value, potentially lifting valuation by up to 10%
Medco Energi • Beneficiaries of positive oil price outlook - earnings revised up by 4% for FY18/19 on higher oil ASP
BUY, Rp1,530(+101%) • MEDC committed to keep its lifting cash cost per barrel of oil equivalent low at US$10/BOE until
2020 - maximising profitability performance
• Further earnings upside from its steady power business under Medco Power Indonesia
BCP • Well-diversified sources of revenue with attractive valuation and decent dividend yield
BUY, Bt39 (+7%) • Strong earnings growth is expected in 2019 due to lower maintenance period with near-term
catalyst from IPO of its subsidiary in 2H18
• Upside from the recent acquisition of E&P business (tentatively to be concluded in 4Q18)
Source: DBS Bank, DBSVI, DBSV TH
Page 7
Regional Industry Focus
Oil & Gas
Peer comparisons
All comparables average 1.9x 1.7x 13.4x 11.2x 5.3x 4.9x 1.3x 10.3% 11.0% 0.35x
Page 8
China / Hong Kong Company Guide
CNOOC Ltd
Version 10 | Bloomberg: 883 HK EQUITY | Reuters: 0883.HK
Refer to important disclosures at the end of this report
11.8
146 Where we differ: We believe the market has yet to fully
9.8
126
106
appreciate the more positive oil price outlook as well as
7.8
86 CNOOC’s revised reserve life, which now looks healthier at 10.3
66
5.8 46 years post booking of Liza Phase I and Libra reserves as well as
Sep-14 Sep-15 Sep-16 Sep-17 Sep-18
re-booking of Long Lake reserves on a better cost outlook there.
Additionally, management had previously implied that CNOOC’s
CNOOC Ltd (LHS) Relative HSI (RHS)
Forecasts and Valuation proven reserve life could be understated by ~40% under SEC
FY Dec (RMBm) 2016A 2017A 2018F 2019F
Turnover 146,490 186,390 229,749 252,694 reporting standards as opposed to the seemingly more
EBITDA 68,977 102,005 137,458 154,676 comprehensive Society of Petroleum Engineers (SPE) reporting.
Pre-tax Profit (5,275) 36,357 72,221 88,009
Net Profit 637 24,677 54,165 66,007 Valuation:
Net Profit Gth (Pre-ex) (%) (96.9) 3,773.9 119.5 21.9
EPS (RMB) 0.01 0.55 1.21 1.48 We value CNOOC based on DCF (WACC 10%; terminal growth
EPS (HK$) 0.02 0.63 1.39 1.70 1%; long-term oil price assumption of US$68/bbl), to derive our
EPS Gth (%) (96.9) 3,773.9 119.5 21.9 HK$16.50 TP.
Diluted EPS (HK$) 0.02 0.63 1.39 1.70
DPS (HK$) 0.35 0.47 0.67 0.71 Key Risks to Our View:
BV Per Share (HK$) 9.82 9.76 10.48 11.47
PE (X) 820.2 21.2 9.6 7.9 Oil price volatility is the key risk. CNOOC’s earnings are
P/Cash Flow (X) 7.2 5.5 4.3 4.0 sensitive to oil prices, which are likely to be dictated by OPEC’s
P/Free CF (X) 21.9 11.7 11.2 8.1
EV/EBITDA (X) 9.3 6.1 4.5 3.9 and the US’s output in the near term.
Net Div Yield (%) 2.6 3.5 5.0 5.3
P/Book Value (X) 1.4 1.4 1.3 1.2
Net Debt/Equity (X) 0.3 0.3 0.2 0.2 At A Glance
ROAE(%) 0.2 6.5 13.7 15.4 Issued Capital (m shrs) 2,778
Earnings Rev (%): Nil 19 Mkt Cap (HK$m/US$m) 17,139 / 2,184
Consensus EPS (RMB) 0.60 0.63 0.62 Major Shareholders (%)
Other Broker Recs: B:18 S:0 H:3 Orchid Garden Investment Co., Ltd. 36.7
Source of all data on this page: Company, DBS Bank (Hong Kong) Li (Hairong) 20.3
Limited (“DBS HK”), Thomson Reuters, HKEX Greenwoods Asset Management Limited 5.3
Free Float (%) 37.7
3m Avg. Daily Val. (US$m) 11.2
ICB Industry: Financials / Real Estate Investment & Services
Page 10
Company Guide
CNOOC Ltd
Appendix 1: A look at CNOOC Ltd's listed history – what drives its share price?
Share price is highly correlated to oil prices, as CNOOC is a pure upstream player
(HK$/sh) (US$/bbl)
25 160
140
20
120
r = 0.89
15 100
80
10 60
40
5
20
0 0
Nov-07
Nov-09
Nov-11
Nov-13
Nov-15
Nov-17
Nov-01
Nov-03
Nov-05
Jul-02
Jul-04
Jul-06
Jul-08
Jul-10
Jul-12
Jul-14
Jul-16
Jul-18
Mar-01
Mar-03
Mar-05
Mar-07
Mar-09
Mar-11
Mar-13
Mar-15
Mar-17
Share Px Brent
Profits, crude oil price, and CNOOC’s share price are closely correlated
(RMB bn) CNO OC operating profit vs. Brent price (US$/bbl) (HK$/sh) CNO OC operating profit vs. share price (RMB bn)
60,000 160 25 60,000
50,000 140 50,000
20
40,000 120 40,000
30,000 100 30,000
15
20,000 80 20,000
10,000 60 10 10,000
0 40 0
5
(10,000) 20 (10,000)
(20,000) 0 0 (20,000)
May-10
May-15
Nov-02
May-05
Nov-12
Nov-17
Nov-07
Jul-04
Jul-09
Jul-14
Jan-02
Mar-06
Jan-07
Mar-11
Jan-17
Mar-01
Sep-08
Jan-12
Sep-13
Sep-03
Mar-16
Jun-03
Jun-06
Jun-09
Jun-12
Jun-15
Dec-16
Jun-18
Dec-01
Dec-04
Dec-07
Dec-10
Dec-13
Mar-01
Mar-04
Mar-07
Mar-10
Mar-13
Mar-16
Sep-02
Sep-05
Sep-08
Sep-11
Sep-14
Sep-17
Page 11
Company Guide
CNOOC Ltd
Balance Sheet:
Balance sheet could de-leverage, but there is headroom for Leverage & Asset Turnover (x)
M&As. Net gearing declined modestly y-o-y from 0.27x as of 0.4
0.50 0.4
end December 2017 to 0.24x by end-June 2018, and we 0.4
believe this trend will persist over the next two years. CNOOC 0.40 0.3
that CNOOC is now more cautious in allocating capital. Thus, 0.10 0.2
0.2
we expect excess cash to be deployed to pay down maturing 0.00 0.2
notes of c.RMB17bn from 2017-2020. Alternatively, excess 2015A 2016A 2017A 2018F 2019F
cash could be deployed to M&As if there are attractive targets Gross Debt to Equity (LHS) Asset Turnover (RHS)
Capital Expenditure
and/or higher dividend payouts. RMBm
80,000.0
c.25% in FY18 on higher oil prices, we assume that DPS in Capital Expenditure (-)
14.0%
Share Price Drivers:
12.0%
Higher oil prices. CNOOC is among the best Chinese proxies to
10.0%
oil and gas prices. Empirically, CNOOC’s share price
8.0%
performance is 90% correlated to oil prices. We believe the
6.0%
continued recovery in oil prices will drive its share price closer
4.0%
to our TP.
2.0%
0.0%
Key Risks: 2015A 2016A 2017A 2018F 2019F
Lower-than-expected oil prices are the key risk. The most Forward PE Band
apparent near-term candidates for such a scenario would be a (x)
surge in US shale output, and/or the OPEC deal to curb
441.1
production levels falling apart. Upside risk would arise from
the reverse – if oil prices rise above expected levels. 341.1
241.1
Company Background
141.1
+2sd: 129.7x
CNOOC is engaged in the exploration and production of +1sd: 80.9x
crude oil and natural gas, primarily within offshore China, 41.1 Avg: 32.1x
-1sd: -16.7x
with exclusive rights to engage in oil and gas exploration in Sep-14
-58.9
Sep-15 Sep-16 Sep-17 Sep-18
1.5
0.5
Sep-14 Sep-15 Sep-16 Sep-17 Sep-18
Page 12
Company Guide
CNOOC Ltd
Key Assumptions
FY Dec 2015A 2016A 2017A 2018F 2019F
Realized oil price (US$/bbl) 51.3 41.4 52.7 67.7 72.8
Realized gas price (US$/mcf) 6.4 5.5 5.8 6.5 7.0
Oil production (mmbbls) 410.3 396.4 388.7 390.9 405.0
Gas production (bcf) 497.7 467.1 474.7 519.0 526.7
Source: Company, DBS HK
Page 13
Company Guide
CNOOC Ltd
Growth
Revenue Gth (%) (25.4) (2.7) 38.2 18.0 14.4
Opg Profit Gth (%) (179.0) 121.7 (304.6) 78.5 86.7
Net Profit Gth (%) N/A 51.9 N/A 0.7 56.8
Margins
Gross Margins (%) (9.7) 19.3 31.4 22.3 44.8
Opg Profit Margins (%) (16.2) 10.5 23.9 15.9 39.0
Net Profit Margins (%) (11.6) 10.5 17.6 9.0 24.1
Source: Company, DBS HK
Page 14
Company Guide
CNOOC Ltd
10.0
9.0
Dec-17
Mar-18
May-18
Jun-18
Sep-17
Apr-18
Sep-18
Jan-18
Jul-18
Nov-17
Feb-18
Aug-18
Oct-17
Oct-17
Source: DBS HK
Analyst: Pei Hwa HO
Page 15
Company Guide
CNOOC Ltd
DBS HK recommendations are based an Absolute Total Return* Rating system, defined as follows:
STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame)
BUY (>15% total return over the next 12 months for small caps, >10% for large caps)
HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps)
FULLY VALUED (negative total return i.e. > -10% over the next 12 months)
SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Sources for all charts and tables are DBS HK unless otherwise specified.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by DBS Bank (Hong Kong) Limited (“DBS HK”). This report is solely intended for the clients of DBS Bank Ltd., DBS HK, DBS
Vickers (Hong Kong) Limited (“DBSV HK”), and DBS Vickers Securities (Singapore) Pte Ltd. (“DBSVS”), its respective connected and associated
corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii)
redistributed without the prior written consent of DBS HK.
The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBS
Bank Ltd., DBS HK, DBSV HK, DBSVS, its respective connected and associated corporations, affiliates and their respective directors, officers,
employees and agents (collectively, the “DBS Group”) have not conducted due diligence on any of the companies, verified any information or
sources or taken into account any other factors which we may consider to be relevant or appropriate in preparing the research. Accordingly, we
do not make any representation or warranty as to the accuracy, completeness or correctness of the research set out in this report. Opinions
expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained in this document
does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. This document is
for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain
separate independent legal or financial advice. The DBS Group accepts no liability whatsoever for any direct, indirect and/or consequential loss
(including any claims for loss of profit) arising from any use of and/or reliance upon this document and/or further communication given in relation
to this document. This document is not to be construed as an offer or a solicitation of an offer to buy or sell any securities. The DBS Group, along
with its affiliates and/or persons associated with any of them may from time to time have interests in the securities mentioned in this document.
The DBS Group, may have positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform
broking, investment banking and other banking services for these companies.
Any valuations, opinions, estimates, forecasts, ratings or risk assessments herein constitutes a judgment as of the date of this report, and there can
be no assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments.
The information in this document is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed, it may
not contain all material information concerning the company (or companies) referred to in this report and the DBS Group is under no obligation to
update the information in this report.
This publication has not been reviewed or authorized by any regulatory authority in Singapore, Hong Kong or elsewhere. There is no planned
schedule or frequency for updating research publication relating to any issuer.
The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and
assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on
which the valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual
results. Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED
UPON as a representation and/or warranty by the DBS Group (and/or any persons associated with the aforesaid entities), that:
(a) such valuations, opinions, estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and
(b) there is any assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk
assessments stated therein.
Please contact the primary analyst for valuation methodologies and assumptions associated with the covered companies or price targets.
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies)
mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the
commodity referred to in this report.
DBS Vickers Securities (USA) Inc (“DBSVUSA”), a US-registered broker-dealer, does not have its own investment banking or research department,
has not participated in any public offering of securities as a manager or co-manager or in any other investment banking transaction in the past
twelve months and does not engage in market-making.
Page 16
Company Guide
CNOOC Ltd
ANALYST CERTIFICATION
The research analyst(s) primarily responsible for the content of this research report, in part or in whole, certifies that the views about the
companies and their securities expressed in this report accurately reflect his/her personal views. The analyst(s) also certifies that no part of his/her
compensation was, is, or will be, directly or indirectly, related to specific recommendations or views expressed in the report. The research analyst (s)
primarily responsible for the content of this research report, in part or in whole, certifies that he or his associate1 does not serve as an officer of
the issuer or the new listing applicant (which includes in the case of a real estate investment trust, an officer of the management company of the
real estate investment trust; and in the case of any other entity, an officer or its equivalent counterparty of the entity who is responsible for the
management of the issuer or the new listing applicant) and the research analyst(s) primarily responsible for the content of this research report or
his associate does not have financial interests2 in relation to an issuer or a new listing applicant that the analyst reviews. DBS Group has
procedures in place to eliminate, avoid and manage any potential conflicts of interests that may arise in connection with the production of
research reports. The research analyst(s) responsible for this report operates as part of a separate and independent team to the investment
banking function of the DBS Group and procedures are in place to ensure that confidential information held by either the research or investment
banking function is handled appropriately. There is no direct link of DBS Group's compensation to any specific investment banking function of the
DBS Group.
1. DBS Bank Ltd, DBS HK, DBSVS, DBSV HK or their subsidiaries and/or other affiliates have a proprietary position in Cnooc Limited (883
HK) recommended in this report as of 03 Sep 2018.
2. Neither DBS Bank Ltd nor DBS HK market makes in equity securities of the issuer(s) or company(ies) mentioned in this Research
Report.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of
which the analyst, his spouse, minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person
accustomed or obliged to act in accordance with the directions or instructions of the analyst.
2
Financial interest is defined as interests that are commonly known financial interest, such as investment in the securities in respect of an issuer or a
new listing applicant, or financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This term
does not include commercial lending conducted at arm's length, or investments in any collective investment scheme other than an issuer or new
listing applicant notwithstanding the fact that the scheme has investments in securities in respect of an issuer or a new listing applicant.
Page 17
China / Hong Kong Company Guide
PetroChina
Version 10 | Bloomberg: 857 HK EQUITY | Reuters: 0857.HK
Refer to important disclosures at the end of this report
Price Relative
HK$
Where we differ: Even though PetroChina is an integrated oil
Relative Index
12.8 213
company, we view the E&P segment as the key to a share price
11.8
10.8
193
173
re-rating, as historically the E&P segment has accounted for the
9.8 153 majority of its operating profits (see Appendix 1).
8.8 133
7.8 113
6.8 93
5.8 73 Catalysts: Stronger-than-expected oil prices could spark upside
4.8
3.8 33
53
to share price. Improvement in E&P, divestment of pipeline
assets, and more favourable pricing/policy on its loss-making
Sep-14 Sep-15 Sep-16 Sep-17 Sep-18
High gas reserves, but crude oil reserves running below peer
average. PetroChina’s total reserve life as of end-December
2017 stood at c.14 years – one of the highest among
integrated peers. However, its reserves are largely skewed
towards natural gas (23-year reserve life), while crude oil
reserve life stands at a much lower ~9 years, which is below
peer average. Major crude oil discoveries or M&A at reasonable
prices for overseas crude oil assets could provide investors with
greater confidence and give the share price a boost.
Page 19
Company Guide
PetroChina
Appendix 1: A look at PetroChina's listed history – what drives its share price?
(US$/bbl) (HK$/sh)
160 25
r = 0. 86
140
20
120
100 15
80
60 10
40
5
20
0 0
Page 20
Company Guide
PetroChina
The link: PetroChina’s upstream segment accounts for the majority of profits when oil prices are not extremely low
Page 21
Company Guide
PetroChina
Balance Sheet:
Manageable gearing and bond maturity profile. PetroChina's Leverage & Asset Turnover (x)
net gearing of c.0.23x as of end-June 2018 sits in the middle of 1.0
0.50
its peer range. We expect PetroChina's to churn positive OCF 1.0
0.9
of c.RMB260-360bn per annum over the next three years. 0.40
0.9
Capex spending should also be maintained at relatively lower 0.30
0.8
levels going forward (guidance of c.RMB226bn for FY18 vs.
0.20 0.8
peak levels of around RMB290-350bn from 2012-2014) given
0.7
the focus on value over volume, freeing up more cash for debt 0.10
0.7
repayments. 0.00 0.6
2015A 2016A 2017A 2018F 2019F
Gross Debt to Equity (LHS) Asset Turnover (RHS)
Share Price Drivers:
Capital Expenditure
Benchmark oil prices. As PetroChina’s E&P segment has the RMBm
largest potential to boost operating profits, any rise or fall in 250,000.0
benchmark oil prices would affect PetroChina’s outlook for its 200,000.0
operating profits.
150,000.0
Shandong) for gasoline in 2H17. While that price war has 3.0%
abated, a resurgence of intense competition could erode
PetroChina’s margins further. 2.0%
1.0%
Company Background
PetroChina is the largest integrated oil company in China with 0.0%
2015A 2016A 2017A 2018F 2019F
operations in the upstream, midstream and downstream PB Band
segments (including chemicals) of the oil and gas value chain. (x)
1.5
1.3
+2sd: 1.18x
1.1
+1sd: 1x
0.9
Avg: 0.81x
0.7
-1sd: 0.62x
0.5
-2sd: 0.44x
0.3
Sep-14 Sep-15 Sep-16 Sep-17 Sep-18
Page 22
Company Guide
PetroChina
Key Assumptions
FY Dec 2015A 2016A 2017A 2018F 2019F
Brent price (US$/bbl) 53.6 45.1 54.8 70.0 75.0
PetroChina realised crude
2,134.0 1,881.0 2,392.0 3,035.0 3,248.5
oil price (RMB/ton)
PetroChina realised
natural gas price 1,371.0 1,097.0 1,236.0 1,515.8 1,584.3
(RMB/cubic metre)
Source: Company, DBS HK
Page 23
Company Guide
PetroChina
Page 24
Company Guide
PetroChina
Growth (QoQ)
Revenue Gth (%) (2.3) (0.1) 15.9 (2.8) 4.3
EBITDA Gth (%) (4.2) (11.9) 42.9 (14.9) 28.3
Opg Profit Gth (%) (14.6) 0.5 17.4 41.6 35.0
Net Profit Gth (%) 22.3 (32.8) 15.8 86.9 66.8
Growth (YoY)
Revenue Gth (%) 24.9 17.1 19.7 9.9 17.4
EBITDA Gth (%) (19.9) 6.1 22.0 2.7 37.5
Opg Profit Gth (%) (54.9) 53.8 31.0 42.5 125.3
Net Profit Gth (%) (51.3) 290.8 (11.3) 78.1 142.8
Margins
Gross Margins (%) 7.1 7.9 (6.5) 8.4 10.0
Opg Profit Margins (%) 3.5 3.5 3.5 5.2 6.7
Net Profit Margins (%) 1.4 1.0 1.0 1.9 3.0
Source: Company, DBS HK
Page 25
Company Guide
PetroChina
Page 26
Company Guide
PetroChina
4.5
4.0
Dec-17
Mar-18
May-18
Jun-18
Apr-18
Sep-17
Sep-18
Jan-18
Jul-18
Nov-17
Feb-18
Aug-18
Oct-17
Oct-17
Source: DBS HK
Analyst: Pei Hwa HO
Page 27
Company Guide
PetroChina
DBS HK recommendations are based an Absolute Total Return* Rating system, defined as follows:
STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame)
BUY (>15% total return over the next 12 months for small caps, >10% for large caps)
HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps)
FULLY VALUED (negative total return i.e. > -10% over the next 12 months)
SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Sources for all charts and tables are DBS HK unless otherwise specified.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by DBS Bank (Hong Kong) Limited (“DBS HK”). This report is solely intended for the clients of DBS Bank Ltd., DBS HK, DBS
Vickers (Hong Kong) Limited (“DBSV HK”), and DBS Vickers Securities (Singapore) Pte Ltd. (“DBSVS”), its respective connected and associated
corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii)
redistributed without the prior written consent of DBS HK.
The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBS
Bank Ltd., DBS HK, DBSV HK, DBSVS, its respective connected and associated corporations, affiliates and their respective directors, officers,
employees and agents (collectively, the “DBS Group”) have not conducted due diligence on any of the companies, verified any information or
sources or taken into account any other factors which we may consider to be relevant or appropriate in preparing the research. Accordingly, we
do not make any representation or warranty as to the accuracy, completeness or correctness of the research set out in this report. Opinions
expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained in this document
does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. This document is
for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain
separate independent legal or financial advice. The DBS Group accepts no liability whatsoever for any direct, indirect and/or consequential loss
(including any claims for loss of profit) arising from any use of and/or reliance upon this document and/or further communication given in relation
to this document. This document is not to be construed as an offer or a solicitation of an offer to buy or sell any securities. The DBS Group, along
with its affiliates and/or persons associated with any of them may from time to time have interests in the securities mentioned in this document.
The DBS Group, may have positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform
broking, investment banking and other banking services for these companies.
Any valuations, opinions, estimates, forecasts, ratings or risk assessments herein constitutes a judgment as of the date of this report, and there can
be no assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments.
The information in this document is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed, it may
not contain all material information concerning the company (or companies) referred to in this report and the DBS Group is under no obligation to
update the information in this report.
This publication has not been reviewed or authorized by any regulatory authority in Singapore, Hong Kong or elsewhere. There is no planned
schedule or frequency for updating research publication relating to any issuer.
The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and
assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on
which the valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual
results. Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED
UPON as a representation and/or warranty by the DBS Group (and/or any persons associated with the aforesaid entities), that:
(a) such valuations, opinions, estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and
(b) there is any assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk
assessments stated therein.
Please contact the primary analyst for valuation methodologies and assumptions associated with the covered companies or price targets.
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies)
mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the
commodity referred to in this report.
DBS Vickers Securities (USA) Inc (“DBSVUSA”), a US-registered broker-dealer, does not have its own investment banking or research department,
has not participated in any public offering of securities as a manager or co-manager or in any other investment banking transaction in the past
twelve months and does not engage in market-making.
Page 28
Company Guide
PetroChina
ANALYST CERTIFICATION
The research analyst(s) primarily responsible for the content of this research report, in part or in whole, certifies that the views about the
companies and their securities expressed in this report accurately reflect his/her personal views. The analyst(s) also certifies that no part of his/her
compensation was, is, or will be, directly or indirectly, related to specific recommendations or views expressed in the report. The research analyst (s)
primarily responsible for the content of this research report, in part or in whole, certifies that he or his associate1 does not serve as an officer of
the issuer or the new listing applicant (which includes in the case of a real estate investment trust, an officer of the management company of the
real estate investment trust; and in the case of any other entity, an officer or its equivalent counterparty of the entity who is responsible for the
management of the issuer or the new listing applicant) and the research analyst(s) primarily responsible for the content of this research report or
his associate does not have financial interests2 in relation to an issuer or a new listing applicant that the analyst reviews. DBS Group has
procedures in place to eliminate, avoid and manage any potential conflicts of interests that may arise in connection with the production of
research reports. The research analyst(s) responsible for this report operates as part of a separate and independent team to the investment
banking function of the DBS Group and procedures are in place to ensure that confidential information held by either the research or investment
banking function is handled appropriately. There is no direct link of DBS Group's compensation to any specific investment banking function of the
DBS Group.
1. DBS Bank Ltd, DBS HK, DBSVS, DBSV HK or their subsidiaries and/or other affiliates have a proprietary position in Petrochina Company
Limited (857 HK) recommended in this report as of 3 Sep 2018.
2. Neither DBS Bank Ltd nor DBS HK market makes in equity securities of the issuer(s) or company(ies) mentioned in this Research
Report.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of
which the analyst, his spouse, minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person
accustomed or obliged to act in accordance with the directions or instructions of the analyst.
2
Financial interest is defined as interests that are commonly known financial interest, such as investment in the securities in respect of an issuer or a
new listing applicant, or financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This term
does not include commercial lending conducted at arm's length, or investments in any collective investment scheme other than an issuer or new
listing applicant notwithstanding the fact that the scheme has investments in securities in respect of an issuer or a new listing applicant.
Page 29
China / Hong Kong Company Guide
China Petroleum & Chem (Sinopec)
Version 9 | Bloomberg: 386 HK EQUITY | Reuters: 0386.HK
Refer to important disclosures at the end of this report
5.5
131
111
Where we differ: We like that the company is working on addressing
4.5
91 the high E&P breakeven and low reserves. In the near term, the IPO of
71
3.5
Sep-14 Sep-15 Sep-16 Sep-17
51
Sep-18
the marketing business and/or spin-off of pipeline assets are potential
China Petroleum & Chem (Sinopec) (LHS) Relative HSI (RHS)
catalysts.
Critical Factors
Sinopec tends to outperform when oil prices are low, or when
the futures curve is in backwardation. Relative to its Chinese oil
major peers, which have their upstream segments contributing
to the majority of group profits, Sinopec does well when oil
prices are low. It also tends to do well (sometimes despite high
oil prices) when the oil futures curve is in backwardation
(indicating strong current demand), such as during the mid-
2011 to mid-2014 period, when the market was pricing in a
steep backwardation in the futures curve of c.US$20/bbl.
When oil prices collapsed in late 2014, Sinopec’s shares
continued to outperform as refinery margins were given a
boost from low oil prices. The curve currently is in steep
backwardation, and our house forecast is for Brent to stay
within the US$65-70/bbl range in the long term, which should
be low enough to be close to Sinopec’s ‘sweet spot’.
Low crude oil reserve life; asset purchases could help resolve
this issue. Sinopec’s crude oil reserve life is low at ~6.1 years,
as key oilfield Shengli (which accounted for 57% of 2017
crude oil output) is mature and not very economical at current
oil prices. The M&A of overseas assets could help alleviate the
concerns over reserve life, as domestic exploration has
apparently failed to yield fantastic results.
Page 31
Company Guide
China Petroleum & Chem (Sinopec)
Appendix 1: A look at Sinopec’s listed history – what drives its share price?
In the long term, Sinopec outperforms when oil prices are either low or expected to move lower (forward curve
implied)
(Indexed, Jan 2010 = 100) (US$/bbl; +ve = contango)
220 30
200 20
180 10
160 0
140 -10
From mid-2011 to mid-
2014, Sinopec's
120 -20
outperformance was
driven by steep
100 -30 backwardation in the
crude futures curve,
80 -40 indicating expectations of
Jan-10 Jan-11 Jan-12 Jan-13 Jan-14 Jan-15 Jan-16 Jan-17 Jan-18
lower oil prices in future
200 120
Since the oil price
180 100 collapse, low oil prices
have helped Sinopec
160 80
outperform, as Sinopec is
more geared towards the
downstream segment vs.
140 60 PetroChina/CNOOC.
120 40
100 20
80 0
Jan-10 Jan-11 Jan-12 Jan-13 Jan-14 Jan-15 Jan-16 Jan-17 Jan-18
Relative performance vs. PetroChina and CNOOC; Sinopec tends to be influenced by refining margins
(Indexed; Jan 2010 = 100) (US$/bbl)
250 12.0
10.0
200
8.0
150
6.0
100
4.0
50
2.0
0 0.0
1/4/2010 1/4/2011 1/4/2012 1/4/2013 1/4/2014 1/4/2015 1/4/2016 1/4/2017 1/4/2018
Page 32
Company Guide
China Petroleum & Chem (Sinopec)
Balance Sheet:
Cash balance and healthy operating cash flows should cover Leverage & Asset Turnover (x)
bond maturities. Sinopec’s bond maturity profile looks fairly 0.45 1.7
0.40
lumpy. However, it is very manageable in light of its current 1.7
0.35
1.6
cash balance of c.Rmb155bn and yearly operating cash flows 0.30
1.6
of c.Rmb190-210bn expected in FY18/FY19. Thus, we do not 0.25
1.5
see any liquidity issues for Sinopec. 0.20
1.5
0.15
1.4
Credit ratios are healthy. Having prudently directed cash to 0.10
0.05 1.4
debt repayments instead of capex over the last two years, 0.00 1.3
Sinopec’s gross debt amount has fallen by c.Rmb142bn (or 2015A 2016A 2017A 2018F 2019F
about 43%) since end-2014, and is now in a near-net cash Gross Debt to Equity (LHS) Asset Turnover (RHS)
Capital Expenditure
position, with a net gearing of just 0.04x as of 2Q18. EBITDA RMBm
interest cover is also not an issue, standing at ~26x for FY17 140,000.0
100,000.0
80,000.0
Share Price Drivers:
Crude oil prices remaining close to Sinopec’s sweet spot 60,000.0
20,000.0
quality upgrades and operational efficiency of new facilities;
0.0
and a potential IPO of the marketing unit could be key share 2015A 2016A 2017A 2018F 2019F
ROE
Key Risks: 10.0%
Oil prices rising to US$80-100/bbl is a scenario that would
likely be negative for Sinopec, though we believe this to be 8.0%
12.5
Avg: 11.9x
10.5
PB Band
1.5
(x)
1.4
1.3
1.2
1.1 +2sd: 1.13x
1.0 +1sd: 1.01x
0.9 Avg: 0.89x
0.8
-1sd: 0.77x
0.7
-2sd: 0.65x
0.6
0.5
Sep-14 Sep-15 Sep-16 Sep-17 Sep-18
Page 33
Company Guide
China Petroleum & Chem (Sinopec)
Page 34
Company Guide
China Petroleum & Chem (Sinopec)
Growth
Revenue Gth (%) (15.6) 7.4 32.6 13.6 11.5
Opg Profit Gth (%) (13.3) 157.8 12.0 (23.6) 56.6
Net Profit Gth (%) (21.6) 277.4 40.1 (12.8) 51.8
Margins
Gross Margins (%) 11.0 9.8 8.8 10.5 10.0
Opg Profit Margins (%) 4.0 4.0 3.4 2.7 4.7
Net Profit Margins (%) 2.3 2.5 2.4 2.0 3.3
Source: Company, DBS HK
Page 35
Company Guide
China Petroleum & Chem (Sinopec)
Page 36
Company Guide
China Petroleum & Chem (Sinopec)
Mar-18
May-18
Jun-18
Apr-18
Sep-17
Sep-18
Jan-18
Jul-18
Nov-17
Feb-18
Aug-18
Oct-17
Oct-17
Source: DBS HK
Analyst: Pei Hwa HO
Page 37
Company Guide
China Petroleum & Chem (Sinopec)
DBS HK recommendations are based an Absolute Total Return* Rating system, defined as follows:
STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame)
BUY (>15% total return over the next 12 months for small caps, >10% for large caps)
HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps)
FULLY VALUED (negative total return i.e. > -10% over the next 12 months)
SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Page 38
Company Guide
China Petroleum & Chem (Sinopec)
ANALYST CERTIFICATION
The research analyst(s) primarily responsible for the content of this research report, in part or in whole, certifies that the views about the
companies and their securities expressed in this report accurately reflect his/her personal views. The analyst(s) also certifies that no part of his/her
compensation was, is, or will be, directly or indirectly, related to specific recommendations or views expressed in the report. The research analyst (s)
primarily responsible for the content of this research report, in part or in whole, certifies that he or his associate 1 does not serve as an officer of
the issuer or the new listing applicant (which includes in the case of a real estate investment trust, an officer of the management company of the
real estate investment trust; and in the case of any other entity, an officer or its equivalent counterparty of the entity who is responsible for the
management of the issuer or the new listing applicant) and the research analyst(s) primarily responsible for the content of this research report or
his associate does not have financial interests2 in relation to an issuer or a new listing applicant that the analyst reviews. DBS Group has
procedures in place to eliminate, avoid and manage any potential conflicts of interests that may arise in connection with the production of
research reports. The research analyst(s) responsible for this report operates as part of a separate and independent team to the investment
banking function of the DBS Group and procedures are in place to ensure that confidential information held by either the research or investment
banking function is handled appropriately. There is no direct link of DBS Group's compensation to any specific investment banking function of the
DBS Group.
1. DBS Bank Ltd, DBS HK, DBSVS, DBSV HK or their subsidiaries and/or other affiliates have a proprietary position in China Petroleum &
Chemical Corporation (386 HK) recommended in this report as of 03 Sep 2018.
2. Neither DBS Bank Ltd nor DBS HK market makes in equity securities of the issuer(s) or company(ies) mentioned in this Research
Report.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of
which the analyst, his spouse, minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person
accustomed or obliged to act in accordance with the directions or instructions of the analyst.
2
Financial interest is defined as interests that are commonly known financial interest, such as investment in the securities in respect of an issuer or a
new listing applicant, or financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This term
does not include commercial lending conducted at arm's length, or investments in any collective investment scheme other than an issuer or new
listing applicant notwithstanding the fact that the scheme has investments in securities in respect of an issuer or a new listing applicant.
Page 39
Indonesia Company Guide
Medco Energi Internasional
Version 10 | Bloomberg: MEDC IJ | Reuters: MEDC.JK Refer to important disclosures at the end of this report
Page 40
ed: KK / sa:MA, CW, CS
Company Guide
Medco Energi Internasional
350.0
120%
328.1
300.0 289.7
288.9 100%
273.4
250.0 80%
220.2
206.5 209.9 210.3
198.8 194.0
193.3
200.0 186.4 189.5 191.6 183.5
170.9 60%
146.1
144.3 144.6
150.0 136.4
135.9
127.7
40%
100.0
20%
50.0
0.0
0%
1Q12
2Q12
3Q12
4Q12
1Q13
2Q13
3Q13
4Q13
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
1Q13
2Q13
3Q13
4Q13
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
Source: Company, DBS Source: Company, DBSVI
70.0% 8 6
60.0% 7
5
6
50.0%
4
5
40.0%
4 3
30.0%
3
2
20.0%
2
1
10.0% 1
0.0% 0 0
1Q12
2Q12
3Q12
4Q12
1Q13
2Q13
3Q13
4Q13
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
1Q13
2Q13
3Q13
4Q13
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
Quarterly oil and gas pricing performance since 1Q12 Quarterly EBITDA trend
Oil Gas EBITDA (US$mn)
180% 180.0
160.0 153.3
160% 148.0
140% 140.0
123.3
120% 120.0 108.2 110.6
0% ‐
1Q13
2Q13
3Q13
4Q13
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
2Q12
3Q12
4Q12
1Q13
2Q13
3Q13
4Q13
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
Page 41
Company Guide
Medco Energi Internasional
Critical Factors
Conservative oil and gas lifting targets; priority on profitability.
Our forecast is in line with management’s guidance on oil and
gas lifting targets, as management adopts a more defensive
stance for its production plan. Management will only focus on
the most profitable shore blocks such as Rimau and South
Natuna Sea Block (SNSB) to keep its cash cost at the lowest
levels. We also see higher gas production volume going forward
as the Aceh gas field kicks off operations this year.
Gas production (BBUPD)
ASP trails our new oil price assumption. We are raising our
crude oil ASP to US$65 per barrel in FY18, followed by US$62
per barrel in FY19. Our crude oil ASP trend is largely in line with
our in-house oil price forecast of US$70-US$75 per barrel in
FY18, US$65-US$70 per barrel in 2019, and US$57 per barrel
thereafter. On the other hand, we see natural gas ASP being
more stable going forward, as MEDC’s gas pricing is based on
long term contracts (in some cases, inflation adjusted).
Keeping lifting cash cost low. We are lowering our lifting cash Crude oil ASP (US$/bbl)
cost forecast to US$10 per barrel. MEDC will halt its offshore
and other high cost blocks to further lower its cost structure this
year. We believe the low cash cost per barrel will sustain for the
next three years. SNSB has a low cost structure, while the Rimau
block should still be able to maintain its production momentum
without significant additional reserve enhancement
programmes in the medium term.
Page 42
Company Guide
Medco Energi Internasional
Appendix 1: A look at Company's listed history – what drives its share price?
MEDC’s share price vs. crude oil price vs. JCI performance Remarks
0.1 Underperformance 4.5 Red box. MEDC’s share price
on weak profitability Consistent earnings underperformed the JCI
and poor capital performance since 4.0 index and crude oil price
0.1 allocation 2Q16 to date led given its poor capital
the share price rally 3.5
allocation and weak
0.1 3.0 profitability trend during the
period.
2.5
0.1
2.0 MEDC’s share price gained
traction in early 2016, given
0.0 1.5 its massive operational
1.0 restructuring that led to low
0.0 New management appointment, focus lifting cash cost per barrel.
on efficiencies and operational 0.5 The share price continued to
restructuring rally after completing the
0.0 0.0
Jan‐09 Jan‐10 Jan‐11 Jan‐12 Jan‐13 Jan‐14 Jan‐15 Jan‐16 Jan‐17
SNSB and AMNT acquisitions
in early 2017.
MEDC share price (US$) ‐ LHS Crude oil price performance ‐ RHS JCI performane ‐ RHS
MEDC ’s share price performance vs. JCI since January 2009 Remarks
Share price (US$) Profitability EBITDAM (%) The new management has set
PX_LAST EBITDA_TO_REVENUE
improvement coupled its focus on lowering MEDC’s
with the stronger lifting cash cost per BOE to
Overseas block lifting performance led
0.2 development dragged 110
around US$10 per BOE, in
the share price
profitability despite Profitability contracted order to cope with the
during the crude oil performance 100
the still high crude oil 90
impending crude oil price
price trend price downtrend, volatility.
followed by share 80
0.1
price 70
60
The efficiency gains, coupled
50
with volume expansion post-
40
SNSB acquisition completion,
0.1
30
have led to a YTD share price
20
rally.
10
0.0 0
Jan‐09
Nov‐09
Jan‐14
Nov‐14
Sep‐10
May‐12
Sep‐15
May‐17
Jul‐11
Mar‐13
Jul‐16
2Q13
3Q13
4Q13
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
Page 43
Company Guide
Medco Energi Internasional
Execution risks. Our earnings forecast also depends on MEDC’s Forward EV/EBITDA Band (x)
execution capability to maintain its cash cost per barrel at low (x)
levels despite the SNSB offshore assets acquisition last year, 7.0
enhance its depleted existing reserves and achieve successful +2 stdev
6.0
exploration investments. Our earnings forecast also depends
on MEDC’s ability to unlock AMNT’s remaining copper and 5.0 +1 stdev
gold reserves.
4.0 Average
Assumption risk. Our new Target Price (TP) includes several 3.0 -1 stdev
Page 44
Company Guide
Medco Energi Internasional
Key Assumptions
FY Dec 2016A 2017A 2018F 2019F 2020F
Oil production (MMBOPD) 19.8 27.0 28.4 29.8 30.7
Gas production (BBUPD) 132 190 200 210 216
Crude oil ASP (US$/bbl) 45.0 50.0 65.0 65.0 63.0
Lifting cost (US$/bbl) 12.0 10.0 10.0 10.0 10.0
Capex (US$mn) (43.9) (313) (212) (323) (324)
Segmental Breakdown
FY Dec 2016A 2017A 2018F 2019F 2020F
Revenues (US$m)
Oil and gas sales 583 855 957 1,019 1,044
Chemicals and other 0.0 0.0 17.0 17.0 17.0
Services 7.00 3.00 17.3 17.3 17.3
Power division 0.0 67.5 140 170 200
Others 0.0 0.0 0.0 0.0 0.0
Total 590 926 1,132 1,224 1,278
Operating profit (US$m)
Oil and gas sales 218 232 340 381 406
Chemicals and other 0.0 0.0 0.0 6.80 6.80
Services 0.0 2.80 1.20 6.90 6.90
Power division 0.0 0.0 0.0 0.0 0.0
Others 0.0 0.0 0.0 0.0 0.0
Total 218 235 342 395 419
Operating profit Margins
Oil and gas sales 37.4 27.1 35.6 37.4 38.9
Chemicals and other N/A N/A 0.0 39.8 39.8
Services 0.0 93.0 6.9 39.8 39.8
Power division N/A 0.0 0.0 0.0 0.0
Others N/A N/A N/A N/A N/A
Total 37.0 25.4 30.2 32.3 32.8
Page 45
Company Guide
Medco Energi Internasional
Growth
Revenue Gth (%) (8.1) 0.4 69.1 (11.9) 0.3
EBITDA Gth (%) (14.9) 20.1 11.5 20.0 3.6
Opg Profit Gth (%) (25.5) 24.1 3.7 57.2 16.2
Net Profit Gth (Pre-ex) (%) (14.8) 130.7 (144.0) (158.1) (8.4)
Margins
Gross Margins (%) 48.2 52.6 36.7 52.5 58.1
Opg Profit Margins (%) 28.6 35.4 21.7 38.7 44.9
Net Profit Margins (%) 19.0 43.6 (11.3) 7.5 6.8
Page 46
Company Guide
Medco Energi Internasional
Source: DBSVI
Analyst: William Simadiputra
Page 47
Company Guide
Medco Energi Internasional
DBSVI recommendations are based an Absolute Total Return* Rating system, defined as follows:
STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame)
BUY (>15% total return over the next 12 months for small caps, >10% for large caps)
HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps)
FULLY VALUED (negative total return i.e. > -10% over the next 12 months)
SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Share price appreciation + dividends
Sources for all charts and tables are DBSVI unless otherwise specified.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT DBS Vickers Sekuritas Indonesia (''DBSVI''). This report is solely intended for the clients of DBS Bank Ltd, its respective
connected and associated corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in any form
or by any means or (ii) redistributed without the prior written consent of PT DBS Vickers Sekuritas Indonesia (''DBSVI'').
The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBS
Bank Ltd, its respective connected and associated corporations, affiliates and their respective directors, officers, employees and agents (collectively,
the “DBS Group”) have not conducted due diligence on any of the companies, verified any information or sources or taken into account any other
factors which we may consider to be relevant or appropriate in preparing the research. Accordingly, we do not make any representation or
warranty as to the accuracy, completeness or correctness of the research set out in this report. Opinions expressed are subject to change without
notice. This research is prepared for general circulation. Any recommendation contained in this document does not have regard to the specific
investment objectives, financial situation and the particular needs of any specific addressee. This document is for the information of addressees
only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate independent legal or financial
advice. The DBS Group accepts no liability whatsoever for any direct, indirect and/or consequential loss (including any claims for loss of profit)
arising from any use of and/or reliance upon this document and/or further communication given in relation to this document. This document is not
to be construed as an offer or a solicitation of an offer to buy or sell any securities. The DBS Group, along with its affiliates and/or persons
associated with any of them may from time to time have interests in the securities mentioned in this document. The DBS Group, may have
positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and
other banking services for these companies.
Any valuations, opinions, estimates, forecasts, ratings or risk assessments herein constitutes a judgment as of the date of this report, and there can
be no assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments.
The information in this document is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed, it may
not contain all material information concerning the company (or companies) referred to in this report and the DBS Group is under no obligation to
update the information in this report.
This publication has not been reviewed or authorized by any regulatory authority in Singapore, Hong Kong or elsewhere. There is no planned
schedule or frequency for updating research publication relating to any issuer.
The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and
assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on
which the valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual
results. Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED
UPON as a representation and/or warranty by the DBS Group (and/or any persons associated with the aforesaid entities), that:
(a) such valuations, opinions, estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and
(b) there is any assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk
assessments stated therein.
Please contact the primary analyst for valuation methodologies and assumptions associated with the covered companies or price targets.
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies)
mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the
commodity referred to in this report.
Page 48
Company Guide
Medco Energi Internasional
DBSVUSA, a US-registered broker-dealer, does not have its own investment banking or research department, has not participated in any public
offering of securities as a manager or co-manager or in any other investment banking transaction in the past twelve months and does not engage
in market-making.
ANALYST CERTIFICATION
The research analyst(s) primarily responsible for the content of this research report, in part or in whole, certifies that the views about the
companies and their securities expressed in this report accurately reflect his/her personal views. The analyst(s) also certifies that no part of his/her
compensation was, is, or will be, directly or indirectly, related to specific recommendations or views expressed in the report. The research analyst (s)
1
primarily responsible for the content of this research report, in part or in whole, certifies that he or his associate does not serve as an officer of the
issuer or the new listing applicant (which includes in the case of a real estate investment trust, an officer of the management company of the real
estate investment trust; and in the case of any other entity, an officer or its equivalent counterparty of the entity who is responsible for the
management of the issuer or the new listing applicant) and the research analyst(s) primarily responsible for the content of this research report or
2
his associate does not have financial interests in relation to an issuer or a new listing applicant that the analyst reviews. DBS Group has
procedures in place to eliminate, avoid and manage any potential conflicts of interests that may arise in connection with the production of
research reports. The research analyst(s) responsible for this report operates as part of a separate and independent team to the investment
banking function of the DBS Group and procedures are in place to ensure that confidential information held by either the research or investment
banking function is handled appropriately. There is no direct link of DBS Group's compensation to any specific investment banking function of the
DBS Group.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of
which the analyst, his spouse, minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person
accustomed or obliged to act in accordance with the directions or instructions of the analyst.
2
Financial interest is defined as interests that are commonly known financial interest, such as investment in the securities in respect of an issuer or
a new listing applicant, or financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This
term does not include commercial lending conducted at arm's length, or investments in any collective investment scheme other than an issuer or
new listing applicant notwithstanding the fact that the scheme has investments in securities in respect of an issuer or a new listing applicant.
Page 49
Thailand Company Guide
Bangchak Petroleum Pcl
Version 7 | Bloomberg: BCP TB | Reuters: BCP.BK Refer to important disclosures at the end of this report
Page 50
ed: TH / sa: CW, CS
Company Guide
Bangchak Petroleum Pcl
WHAT’S NEW
Recap 1H18 earnings performance: BCP's 1H18 net profit Recently, the company has entered into the agreement through
weakened by 30% y-o-y to Bt2,153m. Behind the soft y-o-y its subsidiary to subscribe to the new shares of OKEA (engages
profit was mainly lower average crude run of 88KBD vs 112KBD in E&P business in Norway) in the proportion of up to 90% of
in 1H17, lower crack spread of Gasoline (-11% y-o-y) and Fuel the increased capital which ultimately, BCPR will hold
oil (-90% y-o-y) as well as the lower marketing margin from approximately 45% of total OKEA shares. This transaction is in
Bt0.83/litre to Bt0.79/litre. In 1H18, BCP also booked an extra line with the company’s strategy to strengthen its natural
item of Bt394m which mainly consisted of an inventory gain of resources business. In addition, the oil of OKEA (Draugen and
Bt786m partially offset by the impairment loss of Bt412m. Gjoa) are able to produce the light and sweet crude which will
Stripping out the extra items, BCP would have recorded core enable the company to capture the benefit of expected jump in
earnings profit of Bt1,759m (-46% y-o-y). light and sweet crude once IMO is enforced in 2020.
2H18 outlook is brighter: With normal operation at its refinery Revised down earnings forecast by 13%/14% in FY18/FY19:
and improving crack spreads from lower crude premiums, we We have revised down our earnings forecast by 13% in FY18
expect the upward earnings momentum to resume in 2H18F. and 14% in FY19 to reflect a more conservative view after the
Management has guided that its refinery would operate back to weak 2Q18 results. We have trimmed the GRM margin by
the normal operation at an average capacity of 110kbd in US$0.3/bbl given the weaker-than-expected crack spreads of
2H18. Also, we expect the industry’s GRM to recover in late gasoline (c.17% of BCP’s production) and fuel oil (c.12% of
August-September during the annual shutdown of refineries in BCP’s production). Hence, our TP inched down from Bt40 to
the US prior to the winter season and the high seasonality of Bt39. Our TP of Bt39 is derived from 1.2x P/BV for the oil-
mid distillates. related businesses and DCF-based valuation for the solar
business. In terms of valuation, we also find that BCP is trading
Over the long term, BCP is more focused on diversifying its at attractive valuations and offering dividend yields of 6-7%
revenue source including having more exposure to E&P business during 2017-19F. Hence, we maintain our BUY call with a new
(by acquiring producing or near-producing assets and operating TP of Bt39.
with partners). BCP targets to increase its oil capacity from the
current 2KBD to 15-20KBD by 2023 (which 50:50 of oil and gas
proportion).
Page 51
Company Guide
Bangchak Petroleum Pcl
Critical Factors
Crude run to be ramped up in 2019. We expect BCP’s crude
run to remain high at 101kbd in 2018F and increase to 106kbd
in 2019F. The company is able to resume its refinery back to
106kbd which is above its 2000-2014 average of 87kbd
because of the new crude distillate unit (CDU), which was
installed in 2014 to replace the one damaged by fire in 2012.
The new CDU increases BCP’s crude distillation capacity to
Base GRM (US$/bbl)
120kbd. So far, BCP had optimised its crude run to capture
favourable GRMs in 2017 but its crude run declined in 2018F
due to planned maintenance shutdowns in 2Q18.
Page 52
Company Guide
Bangchak Petroleum Pcl
Company Background
BCP operates a 120-kbd oil refinery located in Bangkok. Its
refined oil products are distributed via petrol stations under its PB Band (x)
retail marketing segment. BCP also invests in alternative
energy, mainly solar and bio fuel.
Page 53
Company Guide
Bangchak Petroleum Pcl
Key Assumptions
FY Dec 2015A 2016A 2017A 2018F 2019F
Crude run (kbd) 113 101 111 101 106
Base GRM (US$/bbl) 9.05 5.99 6.38 6.09 6.46
Marketing margin (Bt/litre) 0.76 0.79 0.77 0.77 0.77
Total capacity - Solar 118 125 130 134 134
(MW)
EBITDAYE contribution - 3,005 2,559 3,088 3,470 3,801
Solar (Bt, mn)
Page 54
Company Guide
Bangchak Petroleum Pcl
Growth
Revenue Gth (%) 0.3 (11.0) 14.7 (1.0) 0.9
EBITDA Gth (%) (11.5) 13.4 (49.7) 66.2 (18.6)
Opg Profit Gth (%) (24.5) 2.8 (116.3) (699.4) (30.4)
Net Profit Gth (Pre-ex) (%) 6.4 51.9 (114.5) (401.5) (42.6)
Margins
Gross Margins (%) 7.7 9.1 4.6 7.7 6.7
Opg Profit Margins (%) 3.9 4.5 (0.6) 3.9 2.7
Net Profit Margins (%) 2.3 3.4 3.1 2.6 2.3
Page 55
Company Guide
Bangchak Petroleum Pcl
Source: DBSVTH
Analyst: Nantika WIANGPHOEM, CFA
THAI-CAC Certified
Corporate Governance CG Rating (as of Oct 2017)
Page 56
Company Guide
Bangchak Petroleum Pcl
DBSVTH recommendations are based an Absolute Total Return* Rating system, defined as follows:
STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame)
BUY (>15% total return over the next 12 months for small caps, >10% for large caps)
HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps)
FULLY VALUED (negative total return i.e. > -10% over the next 12 months)
SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Share price appreciation + dividends
Sources for all charts and tables are DBSVTH unless otherwise specified.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by DBS Vickers Securities (Thailand) Co Ltd (''DBSVTH''). This report is solely intended for the clients of DBS Bank Ltd, its
respective connected and associated corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in
any form or by any means or (ii) redistributed without the prior written consent of DBS Vickers Securities (Thailand) Co Ltd (''DBSVTH'').
The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBS
Bank Ltd, its respective connected and associated corporations, affiliates and their respective directors, officers, employees and agents (collectively,
the “DBS Group”) have not conducted due diligence on any of the companies, verified any information or sources or taken into account any other
factors which we may consider to be relevant or appropriate in preparing the research. Accordingly, we do not make any representation or
warranty as to the accuracy, completeness or correctness of the research set out in this report. Opinions expressed are subject to change without
notice. This research is prepared for general circulation. Any recommendation contained in this document does not have regard to the specific
investment objectives, financial situation and the particular needs of any specific addressee. This document is for the information of addressees
only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate independent legal or financial
advice. The DBS Group accepts no liability whatsoever for any direct, indirect and/or consequential loss (including any claims for loss of profit)
arising from any use of and/or reliance upon this document and/or further communication given in relation to this document. This document is not
to be construed as an offer or a solicitation of an offer to buy or sell any securities. The DBS Group, along with its affiliates and/or persons
associated with any of them may from time to time have interests in the securities mentioned in this document. The DBS Group, may have
positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and
other banking services for these companies.
Any valuations, opinions, estimates, forecasts, ratings or risk assessments herein constitutes a judgment as of the date of this report, and there can
be no assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments.
The information in this document is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed, it may
not contain all material information concerning the company (or companies) referred to in this report and the DBS Group is under no obligation to
update the information in this report.
This publication has not been reviewed or authorized by any regulatory authority in Singapore, Hong Kong or elsewhere. There is no planned
schedule or frequency for updating research publication relating to any issuer.
The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and
assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on
which the valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual
results. Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED
UPON as a representation and/or warranty by the DBS Group (and/or any persons associated with the aforesaid entities), that:
(a) such valuations, opinions, estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and
(b) there is any assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk
assessments stated therein.
Please contact the primary analyst for valuation methodologies and assumptions associated with the covered companies or price targets.
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies)
mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the
commodity referred to in this report.
Page 57
Company Guide
Bangchak Petroleum Pcl
DBSVUSA, a US-registered broker-dealer, does not have its own investment banking or research department, has not participated in any public
offering of securities as a manager or co-manager or in any other investment banking transaction in the past twelve months and does not engage
in market-making.
ANALYST CERTIFICATION
The research analyst(s) primarily responsible for the content of this research report, in part or in whole, certifies that the views about the
companies and their securities expressed in this report accurately reflect his/her personal views. The analyst(s) also certifies that no part of his/her
compensation was, is, or will be, directly or indirectly, related to specific recommendations or views expressed in the report. The research analyst (s)
primarily responsible for the content of this research report, in part or in whole, certifies that he or his associate 1 does not serve as an officer of the
issuer or the new listing applicant (which includes in the case of a real estate investment trust, an officer of the management company of the real
estate investment trust; and in the case of any other entity, an officer or its equivalent counterparty of the entity who is responsible for the
management of the issuer or the new listing applicant) and the research analyst(s) primarily responsible for the content of this research report or
his associate does not have financial interests2 in relation to an issuer or a new listing applicant that the analyst reviews. DBS Group has
procedures in place to eliminate, avoid and manage any potential conflicts of interests that may arise in connection with the production of
research reports. The research analyst(s) responsible for this report operates as part of a separate and independent team to the investment
banking function of the DBS Group and procedures are in place to ensure that confidential information held by either the research or investment
banking function is handled appropriately. There is no direct link of DBS Group's compensation to any specific investment banking function of the
DBS Group.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of
which the analyst, his spouse, minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person
accustomed or obliged to act in accordance with the directions or instructions of the analyst.
2
Financial interest is defined as interests that are commonly known financial interest, such as investment in the securities in respect of an issuer or a
new listing applicant, or financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This term
does not include commercial lending conducted at arm's length, or investments in any collective investment scheme other than an issuer or new
listing applicant notwithstanding the fact that the scheme has investments in securities in respect of an issuer or a new listing applicant.
Page 58
Regional Industry Focus
Oil & Gas
DBS Bank, DBS HK, DBSVI, DBSVTH recommendations are based an Absolute Total Return* Rating system, defined as follows:
STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame)
BUY (>15% total return over the next 12 months for small caps, >10% for large caps)
HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps)
FULLY VALUED (negative total return i.e. > -10% over the next 12 months)
SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Share price appreciation + dividends
Sources for all charts and tables are DBS Bank, DBS HK, DBSVI, DBSVTH unless otherwise specified.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by DBS Bank, DBS Bank (Hong Kong) Limited (''DBS HK''), PT DBS Vickers Sekuritas Indonesia (''DBSVI''), DBS Vickers
Securities (Thailand) Co Ltd (''DBSVTH''). This report is solely intended for the clients of DBS Bank Ltd, its respective connected and associated
corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii)
redistributed without the prior written consent of DBS Bank, DBS HK, DBSVI, DBSVTH.
The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBS
Bank Ltd, its respective connected and associated corporations, affiliates and their respective directors, officers, employees and agents (collectively,
the “DBS Group”) have not conducted due diligence on any of the companies, verified any information or sources or taken into account any other
factors which we may consider to be relevant or appropriate in preparing the research. Accordingly, we do not make any representation or
warranty as to the accuracy, completeness or correctness of the research set out in this report. Opinions expressed are subject to change without
notice. This research is prepared for general circulation. Any recommendation contained in this document does not have regard to the specific
investment objectives, financial situation and the particular needs of any specific addressee. This document is for the information of addressees
only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate independent legal or financial
advice. The DBS Group accepts no liability whatsoever for any direct, indirect and/or consequential loss (including any claims for loss of profit)
arising from any use of and/or reliance upon this document and/or further communication given in relation to this document. This document is not
to be construed as an offer or a solicitation of an offer to buy or sell any securities. The DBS Group, along with its affiliates and/or persons
associated with any of them may from time to time have interests in the securities mentioned in this document. The DBS Group, may have
positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and
other banking services for these companies.
Any valuations, opinions, estimates, forecasts, ratings or risk assessments herein constitutes a judgment as of the date of this report, and there can
be no assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments.
The information in this document is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed, it may
not contain all material information concerning the company (or companies) referred to in this report and the DBS Group is under no obligation to
update the information in this report.
This publication has not been reviewed or authorized by any regulatory authority in Singapore, Hong Kong or elsewhere. There is no planned
schedule or frequency for updating research publication relating to any issuer.
The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and
assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on
which the valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual
results. Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED
UPON as a representation and/or warranty by the DBS Group (and/or any persons associated with the aforesaid entities), that:
(a) such valuations, opinions, estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and
(b) there is any assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk
assessments stated therein.
Please contact the primary analyst for valuation methodologies and assumptions associated with the covered companies or price targets.
Page 59
Regional Industry Focus
Oil & Gas
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies)
mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the
commodity referred to in this report.
DBSVUSA, a US-registered broker-dealer, does not have its own investment banking or research department, has not participated in any public
offering of securities as a manager or co-manager or in any other investment banking transaction in the past twelve months and does not engage
in market-making.
ANALYST CERTIFICATION
The research analyst(s) primarily responsible for the content of this research report, in part or in whole, certifies that the views about the
companies and their securities expressed in this report accurately reflect his/her personal views. The analyst(s) also certifies that no part of his/her
compensation was, is, or will be, directly or indirectly, related to specific recommendations or views expressed in the report. The research analyst (s)
primarily responsible for the content of this research report, in part or in whole, certifies that he or his associate 1 does not serve as an officer of the
issuer or the new listing applicant (which includes in the case of a real estate investment trust, an officer of the management company of the real
estate investment trust; and in the case of any other entity, an officer or its equivalent counterparty of the entity who is responsible for the
management of the issuer or the new listing applicant) and the research analyst(s) primarily responsible for the content of this research report or
his associate does not have financial interests2 in relation to an issuer or a new listing applicant that the analyst reviews. DBS Group has
procedures in place to eliminate, avoid and manage any potential conflicts of interests that may arise in connection with the production of
research reports. The research analyst(s) responsible for this report operates as part of a separate and independent team to the investment
banking function of the DBS Group and procedures are in place to ensure that confidential information held by either the research or investment
banking function is handled appropriately. There is no direct link of DBS Group's compensation to any specific investment banking function of the
DBS Group.
4. DBS Bank Ltd, DBS HK, DBSVS, their subsidiaries and/or other affiliates of DBSVUSA have managed or co-managed a public offering of
securities for Medco Energi Internasional, in the past 12 months, as of 31 Jul 2018.
5. DBSVUSA does not have its own investment banking or research department, nor has it participated in any public offering of securities as a
manager or co-manager or in any other investment banking transaction in the past twelve months. Any US persons wishing to obtain further
information, including any clarification on disclosures in this disclaimer, or to effect a transaction in any security discussed in this document
should contact DBSVUSA exclusively.
Directorship/trustee interests:
7. Danny Teoh Leong Kay, a member of DBS Group Holdings Board of Directors, is a Director of Keppel Corporation as of 30 Jun 2018.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of
which the analyst, his spouse, minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person
accustomed or obliged to act in accordance with the directions or instructions of the analyst.
2
Financial interest is defined as interests that are commonly known financial interest, such as investment in the securities in respect of an issuer or a
new listing applicant, or financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This term
does not include commercial lending conducted at arm's length, or investments in any collective investment scheme other than an issuer or new
listing applicant notwithstanding the fact that the scheme has investments in securities in respect of an issuer or a new listing applicant.
Page 60
Regional Industry Focus
Oil & Gas
RESTRICTIONS ON DISTRIBUTION
General This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or
located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be
contrary to law or regulation.
Australia This report is being distributed in Australia by DBS Bank Ltd. (“DBS”) or DBS Vickers Securities (Singapore) Pte Ltd
(“DBSVS”). DBS holds Australian Financial Services Licence no. 475946.
DBSVS is exempted from the requirement to hold an Australian Financial Services Licence under the Corporation Act 2001
(“CA”) in respect of financial services provided to the recipients. DBSVS is regulated by the Monetary Authority of Singapore
under the laws of Singapore, which differ from Australian laws.
Distribution of this report is intended only for “wholesale investors” within the meaning of the CA.
Hong Kong This report is being distributed in Hong Kong by DBS Bank Ltd, DBS Bank (Hong Kong) Limited and DBS Vickers (Hong Kong)
Limited, all of which are registered with or licensed by the Hong Kong Securities and Futures Commission to carry out the
regulated activity of advising on securities.
This report has been prepared by a person(s) who is not licensed by the Hong Kong Securities and Futures Commission to
carry on the regulated activity of advising on securities in Hong Kong pursuant to the Securities and Futures Ordinance
(Chapter 571 of the Laws of Hong Kong). This report is being distributed in Hong Kong and is attributable to DBS Bank
(Hong Kong) Limited, a registered institution registered with the Hong Kong Securities and Futures Commission to carry on
the regulated activity of advising on securities pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of
Hong Kong).
This report has been prepared by an entity(ies) which is not licensed by the Hong Kong Securities and Futures Commission
to carry on the regulated activity of advising on securities pursuant to the Securities and Futures Ordinance (Chapter 571 of
the Laws of Hong Kong). This report is being distributed in Hong Kong and is attributable to DBS Bank (Hong Kong) Limited,
a registered institution registered with the Hong Kong Securities and Futures Commission to carry on the regulated activity
of advising on securities pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).
For any query regarding the materials herein, please contact Carol Wu (Reg No. AH8283) at equityresearch@dbs.com
Indonesia This report is being distributed in Indonesia by PT DBS Vickers Sekuritas Indonesia.
Malaysia This report is distributed in Malaysia by AllianceDBS Research Sdn Bhd ("ADBSR"). Recipients of this report, received from
ADBSR are to contact the undersigned at 603-2604 3333 in respect of any matters arising from or in connection with this
report. In addition to the General Disclosure/Disclaimer found at the preceding page, recipients of this report are advised
that ADBSR (the preparer of this report), its holding company Alliance Investment Bank Berhad, their respective connected
and associated corporations, affiliates, their directors, officers, employees, agents and parties related or associated with any
of them may have positions in, and may effect transactions in the securities mentioned herein and may also perform or seek
to perform broking, investment banking/corporate advisory and other services for the subject companies. They may also
have received compensation and/or seek to obtain compensation for broking, investment banking/corporate advisory and
other services from the subject companies.
Singapore This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) or DBSVS (Company Regn No.
198600294G), both of which are Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the
Monetary Authority of Singapore. DBS Bank Ltd and/or DBSVS, may distribute reports produced by its respective foreign
entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial
Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert
Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons
only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at 6327 2288 for matters arising from,
or in connection with the report.
Thailand This report is being distributed in Thailand by DBS Vickers Securities (Thailand) Co Ltd.
Page 61
Regional Industry Focus
Oil & Gas
United This report is produced by DBS Bank Ltd, DBS HK, DBSVI, DBSVTH which are regulated by the Monetary Authority of
Kingdom Singapore, Hong Kong Monetary Authority, Otoritas Jasa Keuangan (OJK), Securities and Exchange Commission, Thailand
respectively
This report is disseminated in the United Kingdom by DBS Vickers Securities (UK) Ltd, ("DBSVUK"). DBSVUK is authorised
and regulated by the Financial Conduct Authority in the United Kingdom.
In respect of the United Kingdom, this report is solely intended for the clients of DBSVUK, its respective connected and
associated corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in any
form or by any means or (ii) redistributed without the prior written consent of DBSVUK. This communication is directed at
persons having professional experience in matters relating to investments. Any investment activity following from this
communication will only be engaged in with such persons. Persons who do not have professional experience in matters
relating to investments should not rely on this communication.
Dubai This research report is being distributed by DBS Bank Ltd., (DIFC Branch) having its office at PO Box 506538, 3rd Floor,
International Building 3, East Wing, Gate Precinct, Dubai International Financial Centre (DIFC), Dubai, United Arab Emirates. DBS Bank
Financial Ltd., (DIFC Branch) is regulated by The Dubai Financial Services Authority. This research report is intended only for
Centre professional clients (as defined in the DFSA rulebook) and no other person may act upon it.
United Arab This report is provided by DBS Bank Ltd (Company Regn. No. 196800306E) which is an Exempt Financial Adviser as defined
Emirates in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. This report is for information purposes
only and should not be relied upon or acted on by the recipient or considered as a solicitation or inducement to buy or sell
any financial product. It does not constitute a personal recommendation or take into account the particular investment
objectives, financial situation, or needs of individual clients. You should contact your relationship manager or investment
adviser if you need advice on the merits of buying, selling or holding a particular investment. You should note that the
information in this report may be out of date and it is not represented or warranted to be accurate, timely or complete. This
report or any portion thereof may not be reprinted, sold or redistributed without our written consent.
United States This report was prepared by DBS Bank Ltd, DBS HK, DBSVI, DBSVTH. DBSVUSA did not participate in its preparation. The
research analyst(s) named on this report are not registered as research analysts with FINRA and are not associated persons of
DBSVUSA. The research analyst(s) are not subject to FINRA Rule 2241 restrictions on analyst compensation, communications
with a subject company, public appearances and trading securities held by a research analyst. This report is being distributed
in the United States by DBSVUSA, which accepts responsibility for its contents. This report may only be distributed to Major
U.S. Institutional Investors (as defined in SEC Rule 15a-6) and to such other institutional investors and qualified persons as
DBSVUSA may authorize. Any U.S. person receiving this report who wishes to effect transactions in any securities referred
to herein should contact DBSVUSA directly and not its affiliate.
Other In any other jurisdictions, except if otherwise restricted by laws or regulations, this report is intended only for qualified,
jurisdictions professional, institutional or sophisticated investors as defined in the laws and regulations of such jurisdictions.
INDONESIA THAILAND
PT DBS Vickers Sekuritas (Indonesia) DBS Vickers Securities (Thailand) Co Ltd
Contact: Maynard Priajaya Arif Contact: Chanpen Sirithanarattanakul
DBS Bank Tower 989 Siam Piwat Tower Building,
Ciputra World 1, 32/F 9th, 14th-15th Floor
Jl. Prof. Dr. Satrio Kav. 3-5 Rama 1 Road, Pathumwan,
Jakarta 12940, Indonesia Bangkok Thailand 10330
Tel: 62 21 3003 4900 Tel. 66 2 857 7831
Fax: 6221 3003 4943 Fax: 66 2 658 1269
e-mail: research@id.dbsvickers.com e-mail: research@th.dbs.com
Company Regn. No 0105539127012
Securities and Exchange Commission, Thailand
Page 62